Emmaus Life Sciences Stock Performance
| EMMA Stock | USD 0.01 0 20.37% |
On a scale of 0 to 100, Emmaus Life holds a performance score of 5. The firm shows a Beta (market volatility) of -2.63, which means a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Emmaus Life are expected to decrease by larger amounts. On the other hand, during market turmoil, Emmaus Life is expected to outperform it. Please check Emmaus Life's total risk alpha, downside variance, daily balance of power, as well as the relationship between the maximum drawdown and skewness , to make a quick decision on whether Emmaus Life's price patterns will revert.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Emmaus Life Sciences are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak primary indicators, Emmaus Life sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 2.5 M | |
| Total Cashflows From Investing Activities | -6.4 M |
Emmaus |
Emmaus Life Relative Risk vs. Return Landscape
If you would invest 1.15 in Emmaus Life Sciences on October 3, 2025 and sell it today you would earn a total of 0.15 from holding Emmaus Life Sciences or generate 13.04% return on investment over 90 days. Emmaus Life Sciences is currently generating 0.7976% in daily expected returns and assumes 11.4812% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Emmaus, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Emmaus Life Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Emmaus Life's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Emmaus Life Sciences, and traders can use it to determine the average amount a Emmaus Life's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0695
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | EMMA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Emmaus Life is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Emmaus Life by adding it to a well-diversified portfolio.
Emmaus Life Fundamentals Growth
Emmaus OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Emmaus Life, and Emmaus Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Emmaus OTC Stock performance.
| Return On Asset | -0.12 | |||
| Profit Margin | (1.14) % | |||
| Operating Margin | (0.65) % | |||
| Current Valuation | 49.41 M | |||
| Shares Outstanding | 49.56 M | |||
| Price To Earning | (1.60) X | |||
| Price To Sales | 1.06 X | |||
| Revenue | 20.61 M | |||
| EBITDA | (12.76 M) | |||
| Cash And Equivalents | 982 K | |||
| Cash Per Share | 0.02 X | |||
| Total Debt | 4.65 M | |||
| Debt To Equity | (0.04) % | |||
| Book Value Per Share | (0.76) X | |||
| Cash Flow From Operations | (1.25 M) | |||
| Earnings Per Share | (0.18) X | |||
| Total Asset | 56.73 M | |||
| Retained Earnings | (82.78 M) | |||
| Current Asset | 9.19 M | |||
| Current Liabilities | 7.25 M | |||
About Emmaus Life Performance
By analyzing Emmaus Life's fundamental ratios, stakeholders can gain valuable insights into Emmaus Life's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Emmaus Life has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Emmaus Life has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally. Emmaus Life Sciences, Inc. was founded in 2000 and is headquartered in Torrance, California. Emmaus Life operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 58 people.Things to note about Emmaus Life Sciences performance evaluation
Checking the ongoing alerts about Emmaus Life for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Emmaus Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Emmaus Life Sciences is way too risky over 90 days horizon | |
| Emmaus Life Sciences has some characteristics of a very speculative penny stock | |
| Emmaus Life Sciences appears to be risky and price may revert if volatility continues | |
| Emmaus Life Sciences currently holds 4.65 M in liabilities. Emmaus Life Sciences has a current ratio of 0.14, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Emmaus Life until it has trouble settling it off, either with new capital or with free cash flow. So, Emmaus Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Emmaus Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Emmaus to invest in growth at high rates of return. When we think about Emmaus Life's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 20.61 M. Net Loss for the year was (15.95 M) with profit before overhead, payroll, taxes, and interest of 17.3 M. | |
| Emmaus Life Sciences currently holds about 982 K in cash with (1.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 39.0% of the company shares are held by company insiders |
- Analyzing Emmaus Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Emmaus Life's stock is overvalued or undervalued compared to its peers.
- Examining Emmaus Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Emmaus Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Emmaus Life's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Emmaus Life's otc stock. These opinions can provide insight into Emmaus Life's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Emmaus OTC Stock analysis
When running Emmaus Life's price analysis, check to measure Emmaus Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emmaus Life is operating at the current time. Most of Emmaus Life's value examination focuses on studying past and present price action to predict the probability of Emmaus Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emmaus Life's price. Additionally, you may evaluate how the addition of Emmaus Life to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |